PlantArc Bio Ltd. (TLV:PLNT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 221.20
+1.20 (0.55%)
May 7, 2025, 5:24 PM IDT
PlantArc Bio Revenue
In the year 2024, PlantArc Bio had annual revenue of 4.40M ILS, down -7.95%. PlantArc Bio had revenue of 2.26M in the half year ending December 31, 2024, with 6,169.44% growth.
Revenue
4.40M
Revenue Growth
-7.95%
P/S Ratio
1.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.33M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 920.37M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |